128 related articles for article (PubMed ID: 38049508)
1. Real world analysis on the determinants of survival in primary plasma cell leukemia in the United States.
Saba L; Landau KS; Liang H; Fu CL; Chaulagain CP
Leukemia; 2024 Feb; 38(2):435-437. PubMed ID: 38049508
[No Abstract] [Full Text] [Related]
2. Adult leukemia survival trends in the United States by subtype: A population-based registry study of 370,994 patients diagnosed during 1995-2009.
Bailey C; Richardson LC; Allemani C; Bonaventure A; Harewood R; Moore AR; Stewart SL; Weir HK; Coleman MP;
Cancer; 2018 Oct; 124(19):3856-3867. PubMed ID: 30343495
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
4. The risk of melanoma in patients with chronic lymphocytic leukemia; a population-based study.
Turk T; Saad AM; Al-Husseini MJ; Gad MM
Curr Probl Cancer; 2020 Apr; 44(2):100511. PubMed ID: 32115255
[TBL] [Abstract][Full Text] [Related]
5. Secondary myeloma in patients with chronic lymphoblastic leukemia: A case report and analysis of data from SEER database.
Lin Z; Chen X; Huang Y; Zhao H; Li Z; Xu B
Curr Probl Cancer; 2021 Oct; 45(5):100728. PubMed ID: 33752897
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of primary chronic lymphocytic leukemia in the United States: a cross-sectional study using the
Fu S; Alhaj Z; Huynh D
Leuk Lymphoma; 2024 Apr; 65(4):541-542. PubMed ID: 38247428
[No Abstract] [Full Text] [Related]
7. Survival trends in chronic lymphocytic leukemia across treatment eras: US SEER database analysis (1985-2017).
Alrawashdh N; Sweasy J; Erstad B; McBride A; Persky DO; Abraham I
Ann Hematol; 2021 Oct; 100(10):2501-2512. PubMed ID: 34279676
[TBL] [Abstract][Full Text] [Related]
8. Plasma cell leukemia mimicking chronic lymphocytic leukemia.
Teriaky A; Hsia CC
Blood; 2011 Mar; 117(11):2991. PubMed ID: 21528511
[No Abstract] [Full Text] [Related]
9. Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century.
Pulte D; Redaniel MT; Bird J; Jeffreys M
Eur J Haematol; 2015 Jun; 94(6):540-5. PubMed ID: 25315799
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes among patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who received treatment with a covalent BTK and BCL2 inhibitor in the United States: a real-world database study.
Eyre TA; Hess LM; Sugihara T; He D; Khanal M; Pagel JM; Walgren RA; B Abada P; Konig H; Roeker LE; Mato A
Leuk Lymphoma; 2023 May; 64(5):1005-1016. PubMed ID: 36987650
[TBL] [Abstract][Full Text] [Related]
11. Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era.
Mato A; Jahnke J; Li P; Mehra M; Ladage VP; Mahler M; Huntington S; Doshi JA
Haematologica; 2018 Oct; 103(10):e462-e465. PubMed ID: 29700170
[No Abstract] [Full Text] [Related]
12. Trends of chronic lymphocytic leukemia incidence and mortality in the United States: a population-based study over the last four decades.
Alabrach Y; Mahmoud AA; Abdelhay A; Mansour M; Adra S
Expert Rev Hematol; 2023; 16(10):785-791. PubMed ID: 37515515
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukemia in African Americans.
Coombs CC; Falchi L; Weinberg JB; Ferrajoli A; Lanasa MC
Leuk Lymphoma; 2012 Nov; 53(11):2326-9. PubMed ID: 22646816
[TBL] [Abstract][Full Text] [Related]
14. Trends in leukemia incidence and survival in the United States (1973-1998).
Xie Y; Davies SM; Xiang Y; Robison LL; Ross JA
Cancer; 2003 May; 97(9):2229-35. PubMed ID: 12712476
[TBL] [Abstract][Full Text] [Related]
15. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
16. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study.
Solomon BM; Rabe KG; Slager SL; Brewer JD; Cerhan JR; Shanafelt TD
J Clin Oncol; 2013 Mar; 31(7):930-7. PubMed ID: 23341508
[TBL] [Abstract][Full Text] [Related]
17. Trends in survival of patients with primary plasma cell leukemia: a population-based analysis.
Gonsalves WI; Rajkumar SV; Go RS; Dispenzieri A; Gupta V; Singh PP; Buadi FK; Lacy MQ; Kapoor P; Dingli D; Lust JA; Zeldenrust SR; Hayman SR; Kyle RA; Gertz MA; Kumar SK
Blood; 2014 Aug; 124(6):907-12. PubMed ID: 24957143
[TBL] [Abstract][Full Text] [Related]
18. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
19. Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century.
Pulte D; Castro FA; Jansen L; Luttmann S; Holleczek B; Nennecke A; Ressing M; Katalinic A; Brenner H;
J Hematol Oncol; 2016 Mar; 9():28. PubMed ID: 27000264
[TBL] [Abstract][Full Text] [Related]
20. Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group.
Winqvist M; Asklid A; Andersson PO; Karlsson K; Karlsson C; Lauri B; Lundin J; Mattsson M; Norin S; Sandstedt A; Hansson L; Österborg A
Haematologica; 2016 Dec; 101(12):1573-1580. PubMed ID: 27198718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
